Two cases were classified as AML-MRC (WHO-HAEM4R) or AML-MR (WHO-HAEM5) due to complex karyotypes; however, in ICC, they were classified as AML-TP53 because of TP53 mutation. This evidence concerns the gene TP53 and acute myeloid leukemia.